Dr. Christopher H Chay
Claim this profileMessino Cancer Centers
About Christopher H Chay
Education:
- Earned an MD from the University of North Carolina School of Medicine in 1995.
- Completed a Residency in Internal Medicine at the University of North Carolina Hospitals.
- Undertook a Fellowship in Hematology/Oncology at the University of Michigan Hospitals.
Experience:
- Board Certified in Hematology and Medical Oncology.
- Over 28 years of experience specializing in various types of cancer treatments.
- Practices at Messino Cancer Centers across Franklin, Asheville, and Sylva, North Carolina.
- Affiliated with Mission Hospital, Angel Medical Center, and Harris Regional Hospital.
Area of expertise
Breast Cancer
Christopher H Chay has run 3 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Christopher H Chay has run 3 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Messino Cancer Centers
Messino Cancer Center
Clinical Trials Christopher H Chay is currently running
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting
1 award
Phase 3
4 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting
2 awards
Phase 3
6 criteria
More about Christopher H Chay
Clinical Trial Related
7 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Christopher H Chay has experience with
- Atezolizumab
- Pembrolizumab
- LOXO-305
- Anastrozole
- Imlunestrant
- Tamoxifen
Breakdown of trials Christopher H Chay has run
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher H Chay specialize in?
Christopher H Chay focuses on Breast Cancer and Lung Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Christopher H Chay currently recruiting for clinical trials?
Yes, Christopher H Chay is currently recruiting for 2 clinical trials in Asheville North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Christopher H Chay has studied deeply?
Yes, Christopher H Chay has studied treatments such as Atezolizumab, Pembrolizumab, LOXO-305.
What is the best way to schedule an appointment with Christopher H Chay?
Apply for one of the trials that Christopher H Chay is conducting.
What is the office address of Christopher H Chay?
The office of Christopher H Chay is located at: Messino Cancer Centers, Asheville, North Carolina 28806 United States. This is the address for their practice at the Messino Cancer Centers.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.